For a menopause-related search, choose a source category below. These categories also contain products for other uses; they are not a list of suitable treatments.
Progestogens and Oral Contraceptives
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
ETHINYL ESTRADIOL & LEVONORGESTREL: products 1 to 20 of 20.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Alesse 21 20mcg & 100mcg Tab-21 PkDIN 02236974 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Alesse 28 20mcg & 100mcg Tab-28 PkDIN 02236975 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Alysena 21 20mcg & 100mcg Tab-21 PkDIN 02387875 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Alysena 28 20mcg & 100mcg Tab-28 PkDIN 02387883 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Audrina 21 20mcg & 100mcg Tab-21 PkDIN 02532174 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Audrina 28 20mcg & 100mcg Tab-28 PkDIN 02532182 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Aviane 21 20mcg & 100mcg Tab-21 PkDIN 02298538 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Aviane 28 20mcg & 100mcg Tab-28 PkDIN 02298546 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Indayo 0.03mg & 0.15mg Tab-91 PkDIN 02398869 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Laylaa 21 20mcg & 100mcg Tab-21 PkDIN 02424282 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Laylaa 28 20mcg & 100mcg Tab-28 PkDIN 02424290 | General benefit | $3.9425per source unit | Requirements & sourcesBuild cost plan |
| Min-Ovral 21 0.03mg & 0.15mg Tab-21 PkDIN 02042320 | General benefit | $7.2800per source unit | Requirements & sourcesBuild cost plan |
| Min-Ovral 28 0.03mg & 0.15mg Tab-28 PkDIN 02042339 | General benefit | $7.2800per source unit | Requirements & sourcesBuild cost plan |
| Ovima 21 0.03mg & 0.15mg Tab-21 PkDIN 02387085 | General benefit | $7.2800per source unit | Requirements & sourcesBuild cost plan |
| Ovima 28 0.03mg & 0.15mg Tab-28 PkDIN 02387093 | General benefit | $7.2800per source unit | Requirements & sourcesBuild cost plan |
| Portia 21 0.03mg & 0.15mg Tab-21 PkDIN 02295946 | General benefit | $7.2800per source unit | Requirements & sourcesBuild cost plan |
| Portia 28 0.03mg & 0.15mg Tab-28 PkDIN 02295954 | General benefit | $7.2800per source unit | Requirements & sourcesBuild cost plan |
| Seasonale 0.03mg & 0.15mg Tab-91 PkDIN 02296659 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Triquilar 21 3 Phase Tab-21 PkDIN 00707600 | General benefit | $16.0700per source unit | Requirements & sourcesBuild cost plan |
| Triquilar 28 3 Phase Tab-28 PkDIN 00707503 | General benefit | $16.0700per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:32 Progestogens and Oral Contraceptives.
National Defence, WDH Guide to Menopause, 2026-09-17
Hormone Therapy (HT) previously called Hormone Replacement Therapy replaces estrogen and when needed, progesterone
Ontario Drug Benefit Formulary, Part V, 2026-09-03, p. 38
68:16 Estrogens
68:32 Progestogens and Oral Contraceptives